A Phase 2, Multicenter, International, Open-Label, Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202) ( 2nd to 6th Line)

Type of Cancer
Lymphoma

Site
East Brunswick, Howell

Protocol Number
INCB 50465-202

To Learn More Call
201-510-0910